Cargando…

Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways

Drugs that are already clinically approved or experimentally tested for conditions other than cancer, but are found to possess previously unrecognized cytotoxicity towards malignant cells, may serve as fitting anti-cancer candidates. Methyl N-(6-phenylsulfanyl-1H benzimidazol-2-yl) carbamate [Fenben...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogra, Nilambra, Kumar, Ashok, Mukhopadhyay, Tapas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085345/
https://www.ncbi.nlm.nih.gov/pubmed/30093705
http://dx.doi.org/10.1038/s41598-018-30158-6